Risk of venous thromboembolism in association with factor V leiden in cancer patients – The EDITH case-control study
Sign Up to like & getrecommendations! Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0194973
Abstract: Background Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation. The impact of the… read more here.
Keywords: cancer; leiden mutation; risk; factor leiden ... See more keywords